| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |